Creabilis Therapeutics S.p.A.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 4251
 
 
 
C07K PEPTIDES 3133
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 3164
 
 
 
C08G MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS 1119

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0304,398 POLYMER CONJUGATES OF BOX-A OF HMGB1 AND BOX-A VARIANTS OF HMGB1Apr 28, 17Oct 26, 17[A61K, C12N]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8673347 Polymer conjugates of K-252A and derivatives thereofAug 25, 06Mar 18, 14[A61K, C08G, A61P]
8546547 Polymer conjugates of Box-A of HMGB1 and Box-A variants of HMGB1Sep 14, 07Oct 01, 13[C07K]
8058232 HMGB1 high affinity binding domain Box-A mutantsNov 09, 09Nov 15, 11[A61K, C12P, C12N, C07K]
7635679 Protease resistant mutant of human HMGB1 high affinity binding domain Box-A (HMGB1 Box-A)Mar 05, 07Dec 22, 09[A61K, C12P, C12N, C07K]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2009/0191,253 Use of K-252a and Kinase Inhibitors for the Prevention or Treatment of HMGB1-Associated PathologiesAbandonedJan 29, 07Jul 30, 09[A61K, A61F, A61P]
2008/0305,073 Therapeutic Agents for the Treatment of Hmgb1-Related PathologiesAbandonedJul 04, 05Dec 11, 08[A61K, C07H, C12Q, A61F, A61M]
2006/0234,208 Novel mechanism for hiv-1 entry into host cells and peptides inhibiting this mechanismAbandonedSep 12, 03Oct 19, 06[A61K, C12Q, C40B, C07K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.